Menlo Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-79,359
Closed -$4.69M 31
2024
Q2
$4.69M Sell
79,359
-3,165
-4% -$198K 2.6% 14
2024
Q1
$6.58M Sell
82,524
-2,265
-3% -$173K 3.77% 12
2023
Q4
$6.69M Sell
84,789
-535
-0.6% -$38.1K 4.12% 10
2023
Q3
$5.96M Sell
85,324
-2,990
-3% -$212K 3.91% 10
2023
Q2
$6.11M Buy
88,314
+20,626
+30% +$1.47M 3.85% 9
2023
Q1
$5.03M Sell
67,688
-470
-0.7% -$39.4K 3.45% 12
2022
Q4
$6.35M Hold
68,158
4.77% 8
2022
Q3
$6.5M Sell
68,158
-1,115
-2% -$110K 4.56% 10
2022
Q2
$6.42M Buy
69,273
+335
+0.5% +$32.7K 4.26% 8
2022
Q1
$6.98M Buy
68,938
+1,190
+2% +$125K 3.69% 10
2021
Q4
$6.99M Sell
67,748
-2,400
-3% -$222K 3.47% 11
2021
Q3
$5.95M Buy
70,148
+5,913
+9% +$495K 3.15% 11
2021
Q2
$5.36M Buy
64,235
+4,095
+7% +$335K 2.89% 13
2021
Q1
$4.52M Buy
60,140
+10,000
+20% +$728K 2.69% 16
2020
Q4
$3.42M Buy
50,140
+24,925
+99% +$1.62M 2.27% 18
2020
Q3
$1.47M Sell
25,215
-25,042
-50% -$1.56M 1.15% 23
2020
Q2
$3.27M Buy
+50,257
New +$3.16M 2.55% 15

Other funds holding CVS

Menlo Advisors's CVS Position: Q3 2024 in Review

Menlo Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 79,359 shares — an estimated $4.69M sold.

Menlo Advisors first reported a position in CVS in Q2 2020 and held it in 17 quarters. The position peaked at $6.99M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Menlo Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Menlo Advisors sold 79,359 CVS Health shares in Q3 2024, an estimated $4.69M.
  • Menlo Advisors first reported a position in CVS Health in Q2 2020 and held it in 17 quarters.
  • Menlo Advisors's CVS Health position peaked at $6.99M in Q4 2021.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Menlo Advisors's 13F filing for Q3 2024, filed 18 Nov 2024.